Catheter Precision has received notification of the issuance of its first LockeT patent in the country of China. Locket is a suture retention device used in the closure of percutaneous catheter access sites during any number of catheter procedures including electrophysiology, structural heart, and vascular surgery procedures. Locket is currently sold in the US and select international territories. Catheter Precision is awaiting CE mark certification, expected in the first quarter of 2025, which opens up the large market of European countries.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VTAK:
- Catheter Precision expands LockeT distribution to Middle East
- Catheter Precision reports first purchase order for LockeT in Pacific Northwest
- Catheter Precision announces presentation at ESC Symposium
- Catheter Precision reports LockeT purchase order in greater Chicago area
- Catheter Precision reports Q2 EPS ($5.57) vs. ($2.94) last year